BACKGROUND: Kidney function decreases with age. A potential mechanistic explanation for kidney and allograft half-life has evolved through the realization that linear reduction in glomerular podocyte density could drive progressive glomerulosclerosis to impact both native kidney and allograft half-lives. METHODS: Predictions from podometrics (quantitation of podocyte parameters) were tested using independent pathologic, functional, and outcome data for native kidneys and allografts derived from published reports and large registries. RESULTS: With age, native kidneys exponentially develop glomerulosclerosis, reduced renal function, and end-stage kidney disease, projecting a finite average kidney life span. The slope of allograft failure rate versus age parallels that of reduction in podocyte density versus age. Quantitative modeling projects allograft half-life at any donor age, and rate of podocyte detachment parallels the observed allograft loss rate. CONCLUSION: Native kidneys are designed to have a limited average life span of about 100-140 years. Allografts undergo an accelerated aging-like process that accounts for their unexpectedly short half-life (about 15 years), the observation that older donor age is associated with shorter allograft half-life, and the fact that long-term allograft survival has not substantially improved. Podometrics provides potential readouts for these processes, thereby offering new approaches for monitoring and intervention. FUNDING: National Institutes of Health.
BACKGROUND: Kidney function decreases with age. A potential mechanistic explanation for kidney and allograft half-life has evolved through the realization that linear reduction in glomerular podocyte density could drive progressive glomerulosclerosis to impact both native kidney and allograft half-lives. METHODS: Predictions from podometrics (quantitation of podocyte parameters) were tested using independent pathologic, functional, and outcome data for native kidneys and allografts derived from published reports and large registries. RESULTS: With age, native kidneys exponentially develop glomerulosclerosis, reduced renal function, and end-stage kidney disease, projecting a finite average kidney life span. The slope of allograft failure rate versus age parallels that of reduction in podocyte density versus age. Quantitative modeling projects allograft half-life at any donor age, and rate of podocyte detachment parallels the observed allograft loss rate. CONCLUSION: Native kidneys are designed to have a limited average life span of about 100-140 years. Allografts undergo an accelerated aging-like process that accounts for their unexpectedly short half-life (about 15 years), the observation that older donor age is associated with shorter allograft half-life, and the fact that long-term allograft survival has not substantially improved. Podometrics provides potential readouts for these processes, thereby offering new approaches for monitoring and intervention. FUNDING: National Institutes of Health.
Authors: Akihiro Fukuda; Larysa T Wickman; Madhusudan P Venkatareddy; Yuji Sato; Mahboob A Chowdhury; Su Q Wang; Kerby A Shedden; Robert C Dysko; Jocelyn E Wiggins; Roger C Wiggins Journal: Kidney Int Date: 2011-09-21 Impact factor: 10.612
Authors: Kathryn E White; Rudolf W Bilous; Sally M Marshall; Meguid El Nahas; Giuseppe Remuzzi; Giampiero Piras; Salvatore De Cosmo; GianCarlo Viberti Journal: Diabetes Date: 2002-10 Impact factor: 9.461
Authors: Brian J Nankivell; Richard J Borrows; Caroline L-S Fung; Philip J O'Connell; Richard D M Allen; Jeremy R Chapman Journal: N Engl J Med Date: 2003-12-11 Impact factor: 91.245
Authors: Iasmina M Craici; Steven J Wagner; Tracey L Weissgerber; Joseph P Grande; Vesna D Garovic Journal: Kidney Int Date: 2014-02-26 Impact factor: 10.612
Authors: Stuart J Shankland; Yuliang Wang; Andrey S Shaw; Joshua C Vaughan; Jeffrey W Pippin; Oliver Wessely Journal: J Am Soc Nephrol Date: 2021-11 Impact factor: 10.121
Authors: Abhijit S Naik; Jawad Aqeel; Su Q Wang; Mahboob Chowdhury; Kevin He; Roger C Wiggins Journal: Clin Transplant Date: 2021-11-02 Impact factor: 2.863
Authors: Dhruti P Chen; Ziad S Zaky; Jesse D Schold; Leal C Herlitz; Rasha El-Rifai; Paul E Drawz; Leslie A Bruggeman; Laura Barisoni; Susan L Hogan; Yichun Hu; John F O'Toole; Emilio D Poggio; John R Sedor Journal: Clin Transplant Date: 2021-02-10 Impact factor: 2.863
Authors: Jennifer A Schaub; Christopher L O'Connor; Jian Shi; Roger C Wiggins; Kerby Shedden; Jeffrey B Hodgin; Markus Bitzer Journal: J Clin Pathol Date: 2021-01-11 Impact factor: 4.463
Authors: Rajasree Menon; Edgar A Otto; Celine C Berthier; Viji Nair; Evan A Farkash; Jeffrey B Hodgin; Yingbao Yang; Jinghui Luo; Kenneth J Woodside; Haniyeh Zamani; Silas P Norman; Roger C Wiggins; Matthias Kretzler; Abhijit S Naik Journal: Kidney Int Date: 2021-12-22 Impact factor: 18.998